It is generally accepted that metabolism is able to shape the immune response. Only
recently we are gaining awareness that the metabolic crosstalk between different tumor …

Cancer is the second most important cause of death and new therapy modalities continue to
be developed and evolved. Cancer cells' metabolism is far different from the normal, healthy …

Resistance of cancer cells to chemotherapy is the first cause of cancer-associated death.
Thus, new strategies to deal with the evasion of drug response and to improve clinical …

Colorectal cancer (CRC) is a disease with constantly increasing incidence and high
mortality. The treatment efficacy could be curtailed by drug resistance resulting from poor …

Objectives To understand underlying changes in pretreatment serum inflammatory markers
associated with thymic epithelial tumors (TETs) development. Methods A retrospective …

The leukaemias are a heterogeneous group of blood cancers, which together, caused
310,000 deaths in 2016. Despite significant research into their biology and therapeutics …

The history of modern oncology started around eighty years ago with the introduction of
cytotoxic agents such as nitrogen mustard into the clinic, followed by multi-agent …

Cancer cell proliferation and their adaptation to tough environments depend critically on
metabolic pathways. The pathological, phenotypic, and structural level understanding of …